Rare diseases
Investigational molecules
Locations
Back to Romania9 clinical trials in Targu, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
RomaniaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
RomaniaStudy of ISIS 678354 for Patients with Severe High Triglycerides
RomaniaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
RomaniaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
RomaniaEfficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial
RomaniaStudy on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy
RomaniaStudy on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction
RomaniaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on heart failure prevention and treatment of hypertrophic cardiomyopathy. Studies evaluating innovative combination therapies and novel compounds for cardiac conditions.
Research includes assessment of new therapeutic approaches for managing cardiovascular complications and improving patient outcomes.
Advanced research in blood disorders and cancer treatments, including studies on lymphoma and leukemia. Innovative therapies being evaluated for rare conditions like paroxysmal nocturnal hemoglobinuria.
Focus on developing targeted treatments and improving patient care in hematologic conditions.
Comprehensive studies investigating treatments for epilepsy and multiple sclerosis. Research evaluating extended-release formulations and novel therapeutic approaches.
Emphasis on improving quality of life and treatment outcomes for patients with neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
